Vivien Santillan is the Regional Director for Asia and a Program Consultant at Novatek International, a Canadian life-science IT firm providing regulatory compliant software solutions to the pharmaceutical, biotech, and healthcare industries. With over 25 years of experience in information technology and services, she has played a pivotal role in the pharmaceutical sector for the past 17 years, assisting companies in achieving regulatory compliance through technical assistance, gap analysis, and training. Vivien's notable leadership roles include serving as President of the ISPE Philippines Affiliate (2017-2020) and Chair of the ISPE Asia Pacific Council (2019-2020). She is also a Director on the ISPE International Board of Directors (2024-2026) and holds key positions in various ISPE committees, such as Chair of the GAMP® South-Asia Steering Committee and Past-Chair of the Women in Pharma® International Steering Committee. Additionally, she actively participates in several ISPE Community of Practice (COP) including the Drug Shortages Initiative Team and QC/Analytical. An accomplished resource and trainer, Vivien has addressed numerous topics for the industry and regulators including computer system validation, data integrity, digitalization and contamination control strategy. She holds a degree in Computer Applications from De La Salle University and is certified in Total Quality Management (TQM). As an active ISPE member, Vivien envisions expanding ISPE's reach, providing equitable access to relevant training and education, and strengthening its role as a valuable partner to affiliates and chapters in overcoming industry challenges.
As I conclude my tenure as Chair of the Women in Pharma® International Steering Committee, I reflect on a journey that has been professionally enriching and personally transformative.
As Chair of ISPE’s Women in Pharma® International Steering Committee, I am proud to share a dynamic midyear update on the incredible momentum we have built together throughout 2025. This year has been marked by transformative progress, reinforcing our role as a driving force on leadership connection, and innovation across the global pharmaceutical community.
In the ever-evolving landscape of the pharmaceutical industry, the Women in Pharma® Steering Committee has taken significant steps to foster collaboration, share insights, and strengthen community engagement among the ISPE community. Over the past year, our commitment to these initiatives has opened doors for Women in Pharma Affiliate and Chapter leaders to connect, exchange best practices,...
As we approach the end of another impactful year, it is a pleasure to reflect on the outstanding achievements and contributions of ISPE’s Women in Pharma community, both regionally and internationally.
The 2024 ISPE Annual Meeting & Expo, taking place 13 – 16 October in Orlando, Florida, USA, and virtually, stands out as a key event in the pharmaceutical industry. Known for its rich educational offerings, the annual event serves as a dynamic platform where professionals gather...
The emergence of new modalities and innovations on drug development and research, such as advanced therapy medicinal products (ATMPs) and personalized and precise therapies, presents new opportunities for the treatment and management of diseases and injuries. As these innovations continue to evolve, the regulatory landscape likewise evolves and this has led to the production of higher-quality,...